The North American syringes market was estimated to be USD 3.62 billion in 2022 and is predicted to reach USD 5.24 billion by 2027, showcasing a CAGR of 7.7% from 2022 to 2027.
Syringes have been said to play an essential role in administering vaccines and nutritional supplements and providing various medications since this involves injecting the drug directly into the bloodstream, which results in less time for more significant action on the target site. Due to this vast benefit of syringes, they have been increasingly being adopted for many years. Moreover, the rise in chronic diseases such as Cancer, which has been reported as the second leading cause of death in the region of North America, after heart disease, with 602,350 cancer deaths reported in 2020 in the United States by the Centers for Disease Control and Prevention (CDC), has further increased the adoption of syringes across North America.
Also, the growing trend of using POP syringes due to the rising need to reduce the death rate across the entire region from various diseases, along with increased activities of various NGOs and healthcare organizations to raise awareness, and the high frequency of manufacturers focusing more on delivering well-established technologies to the patients are the factors which are further expected to drive demand for syringes in the years to come in the North American market.
Furthermore, the trend of self-administered injections such as insulin pens is growing significantly owing to the rising cases of diabetes across North America, which is expected to boost syringe sales. Moreover, the high adoption of syringes in various industries for various applications such as in dentistry, anesthesia, and many others is leading the syringe manufacturers to continually innovate and develop new syringe technologies with better functionality and collaborating with other manufacturers of syringes for better profit and expansion of their customer base. It is also fuelling the demand for injectable drugs, which act as critical drivers for the growth of the syringe market in North America.
However, the increasing number of cases involving needle stick injuries, strict federal rules, and shortage of specialists in treating hormonal imbalances, which can be balanced through correct injectable drug delivery, hamper the syringes market growth in North America. In addition, the availability of cheaper alternatives and different drug delivery methods requiring different specialists in various fields are some of the major factors anticipated to have a substantial negative impact on the growth of the syringes market in North America.
This research report on the North American syringes market has been segmented and sub-segmented into the following categories:
The North American region had the most significant global market share in 2021. The growth of the North American syringe market is driven by factors such as the increasing incidence of chronic diseases which can be most preferably treated by injectable drugs, leading to the growing preference for administering health care substances by injection because of its faster action and the increase in vaccination programs in the recent years. This is expected to raise the overall sales of syringes in North America, further driving the market for syringes in this region.
In countries such as the U.S. and Canada, which are anticipated to dominate the syringes market of North America, healthcare providers follow safe injection practices regularly as part of standard precautions, which further helps prevent the transmission of disease through multi-dose vials, syringes, or needles. Also, many of the manufacturers in these countries are focusing on expanding their manufacturing bases through the provision of low-cost syringes and other drugs to medical settings through the most cost-effective R&D, primarily due to the emergence of infections that need to be treated using pathological injections, the growing popularity of cyclic olefin polymer syringes, along with the rising awareness among people for vaccination to be safe from the spread of various acute infections. These are some factors further responsible for driving the growth of the syringes market in North America.
KEY MARKET PLAYERS:
A few of the noteworthy companies operating in the North American syringes market profiled in this report are Terumo Corporation, B. Braun Medical Inc., Medtronic plc, Becton Dickinson and Company, Smiths Medical, Hindustan Syringes & Medical Devices Limited, NIPRO Corporation, Gerresheimer AG, SCHOTT AG, and CODAN Medizinische Geräte GmbH & Co KG.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com